Goto Biopharm: Net profit loss of 11.1525 million yuan in the first half of 2025, a decrease of 117.88%

Zhitong
2025.08.28 12:29

Goto Biopharm announced that in the first half of 2025, operating revenue was 302 million yuan, a year-on-year increase of 29.33%. The net profit loss was 11.1525 million yuan, a decrease of 117.88%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.